CapEx taxonomy disclosure
Financial year 2023 | 2023 | Sustantial contribution criteria | DNSH criteria | ||||||||||||||||
Economic activities | Code | CapEx (Meuro) | Proportion of CapEx 2023 (%) | Climate change mitigation | Climate change adaptation | Water | Circular economy | Pollution | Biodiversity | Climate change mitigation | Climate change adaptation | Water | Circular economy | Pollution | Biodiversity | Minimum safeguards | Proportion of Taxonomy-aligned (A.1.) or eligible (A.2.) CapEx, year 2022 | Category (enabling activity) | Category (transitional activity) |
A. Taxonomy eligible activities | |||||||||||||||||||
A.1. Environmentally sustainable activities (Taxonomy-aligned) | |||||||||||||||||||
Manufacture of other low carbon technologies1 | CCM 3,6 | 50.5 | 35.0% | Y | N/EL | N/EL | N/EL | N/EL | N/EL | Y | Y | Y | Y | Y | Y | Y | 43.9% | E | |
CapEx of environmentally sustainable activities (Taxonomy-aligned) (A.1) | 50.5 | 35.0% | 35.0% | 0% | 0% | 0% | 0% | 0% | Y | Y | Y | Y | Y | Y | Y | 43.9% | |||
Of which enabling | 50.5 | 35.0% | 35.0% | 0% | 0% | 0% | 0% | 0% | Y | Y | Y | Y | Y | Y | Y | 43.9% | E | ||
Of which transitional | - | - | - | - | - | - | - | - | - | - | - | T | |||||||
A.2. Taxonomy-eligible but not environmentally sustainable activities (not Taxonomy-aligned activities) | |||||||||||||||||||
Manufacture of other low carbon technologies2 | CCM 3,6 | 10.8 | 7.5% | EL | N/EL | N/EL | N/EL | N/EL | N/EL | 8.1% | |||||||||
CapEx of Taxonomy-eligible but not environmentally sustainable activities (not Taxonomy-aligned activities) (A.2) | 10.8 | 7.5% | 7.5% | 0% | 0% | 0% | 0% | 0% | 8.1% | ||||||||||
A. CapEx of Taxonomy- eligible activities (A.1+A.2)3 | 61.3 | 42.5% | 42.5% | 0% | 0% | 0% | 0% | 0% | 52.0% | ||||||||||
B. Taxonomy non eligible activities | |||||||||||||||||||
CAPEX of Taxonomy non-eligible activities (B) | 82.9 | 57.5% | |||||||||||||||||
Total (A+B)4 | 144.2 | 100.0% |
Proportion of CAPEX / Total CAPEX | ||
Taxonomy-aligned per objective | Taxonomy-eligible per objective | |
CCM | 35.0% | 42.5% |
CCA | 0% | 0% |
WTR | 0% | 0% |
CE | 0% | 0% |
PPC | 0% | 0% |
BIO | 0% | 0% |
1 | CapEx supporting lactic acid sales for PLA, consisting of a) CapEx related to the existing site in Rayong, Thailand, based on the share of net sales of lactic acid produced at Corbion Rayong in the PLA segment and b) CapEx related to the construction of a new site for the expansion of manufacturing capacity of lactic acid for PLA (CapEx plan). The aligned CapEx (€ 50.5 million) is split in the following categories: property, plant, and equipment (€ 50.2 million) and capitalized right-of-use assets (€ 0.3 million). Of the aligned property, plant, and equipment, € 48.7 million is related to the CapEx Plan. The expected capital expense during the remaining period of the CapEx plan is € 10.4 million and the expected start-up is in the first quarter of 2024. |
2 | CapEx supporting sales of AlgaPrime DHA. This includes all CapEx at our Orindiúva, Brazil, manufacturing facility. |
3 | CapEx supporting sales of AlgaPrime DHA and sales of lactic acid in the PLA segment. No double counting because only climate mitigation is considered, and the activities are geographically separated. |
4 | Reported under the capital expenditure and acquisition of group companies sections of property, plant, and equipment; leases; and intangible fixed assets in the year (see Notes 10, 11, and 12 of the Consolidated statement of financial position). |